Oxygen-Dependent Microbial Killing by Phagocytes

New England Journal of Medicine

Volumn 298, Issue 12, 1978, Pages 659-668

  Babior, Bernard M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

BACTERIAL INFECTION; BIOLOGICAL MODEL; BLOOD AND HEMOPOIETIC SYSTEM; IN VITRO STUDY; METHODOLOGY; MYCOBACTERIUM; NEUTROPHIL; PHAGOCYTE; PHAGOCYTOSIS; SHORT SURVEY;

BACTERIA; HUMAN; HYDROGEN PEROXIDE; HYDROXIDES; LUMINESCENCE; NAD; NADH, NADPH OXIDOREDUCTASES; NADP; NITROBLUE TETRAZOLIUM; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PEROXIDASE; PHAGOCYTES; PHAGOCYTOSIS; SUPEROXIDE DISMUTASE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0017834531     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197803232981205     Document Type: Review

References (100)

1. Metschnikoff E: Untersuchungen über die intracellulare Verdauung bei wirbellosen Thieren. Arb Zoologischen Inst Univ Wien 5: 141–168, 1883
2. Shaw GB: Selected Plays with Prefaces. Vol 1. New York, Dodd Mead, 1957, p 110
3. Keller HU, Hess MW, Cottier H: Physiology of chemotaxis and random motility. Semin Hematol 12: 47–57, 1975
4. Zigmond SH: Mechanisms of sensing chemical gradients by polymorphonuclear leukocytes. Nature 249: 450–452, 1974
5. Stossel TP: Phagocytosis: recognition and ingestion. Semin Hematol 12: 83–116, 1975
6. Zucker-Franklin D, Hirsch JG: Electron microscope studies on the degranulation of rabbit peritoneal leukocytes during phagocytosis. J Exp Med 120: 569–576, 1964
7. Sbarra AJ, Karnovsky ML: The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem 234: 1355–1362, 1959
8. Bainton DF, Ullyot JL, Farquhar MG: The development of neutrophilic polymorphonuclear leukocytes in human bone marrow: origin and content of azurophil and specific granules. J Exp Med 134: 907–934, 1971
9. Stossel TP: Phagocytosis. N Engl J Med 290: 717–723, 774–780, 833–839, 1974
10. Baldridge CW, Gerard RW: The extra respiration of phagocytosis. Am J Physiol 103: 235–236, 1933
11. Karnovsky ML: The metabolism of leukocytes. Semin Hematol 5: 156–165, 1968
12. Simon LM, Robin ED, Phillips JR, et al: Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2. J Clin Invest 59: 443–448, 1977
13. Oren R, Farnham AE, Saito K, et al: Metabolic patterns in three types of phagocytizing cells. J Cell Biol 17: 487–501, 1963
14. Baehner RL, Johnston RB Jr: Metabolic and bactericidal activities of human eosinophils. Br J Haematol 20: 277–285, 1971
15. Iyer GYN, Islam MF, Quastel JH: Biochemical aspects of phagocytosis. Nature 192: 535–541, 1961
16. Beck WS: Occurrence and control of the phosphogluconate oxidation pathway in normal and leukemic leukocytes. J Biol Chem 232: 271–283, 1958
17. McCord JM, Fridovich I: Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049–6055, 1969
18. Babior BM, Kipnes RS, Curnutte JT: Biological defense mechanisms: the production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52: 741–744, 1973
19. Drath DB, Karnovsky ML: Superoxide production by phagocytic leukocytes. J Exp Med 141: 257–262, 1975
20. Weening RS, Wever R, Roos D: Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med 85: 245–252, 1975
21. Johnston RB Jr, Keele BB Jr, Misra HP, et al: The role of superoxide anion generation in phagocytic bactericidal activity: studies with normal and chronic granulomatous disease leukocytes. J Clin Invest 55: 1357–1372, 1975
22. Goldstein IM, Roos D, Kaplan HB, et al: Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest 56: 1155–1163, 1975
23. Root RK, Metcalf JA: H2O2 release from human granulocytes during phagocytosis: relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B treated cells. J Clin Invest 60: 1266–1279, 1977
24. Sagone AL Jr, King GW, Metz EN: A comparison of the metabolic response to phagocytosis in human granulocytes and monocytes. J Clin Invest 57: 1352–1358, 1976
25. Tauber AI, Goetzl EJ, Babior BM: The production of superoxide (O– 2) by human eosinophils. Blood 48: 968, 1976
26. Klebanoff SJ, Durack DT, Rosen H, et al: Functional studies on human peritoneal eosinophils. Infect Immun 17: 167–173, 1977
27. Cheson BD, Curnutte JT, Babior BM: The oxidative killing mechanisms of the neutrophil. Prog Clin Immunol 3: 1–65, 1977
28. Root RK, Metcalf J, Oshino N, et al: H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation and some regulating factors. J Clin Invest 55: 945–955, 1975
29. Curnutte JT, Alfred RH, Karnovsky ML, et al: Reversible stimulation of the O– 2-forming system in human polymorphonuclear leukocytes (PMNs). Clin Res 25: 337A, 1977
30. Cohen HJ, Chovaniec ME: Superoxide production by digitonin-stimulated guinea pig granulocytes: the effects of N-ethyl maleimide, divalent cations, and glycolytic and mitochondrial inhibitors on the activation of the superoxide generating system. J Clin Invest (in press)
31. Klebanoff SJ, Hamon CB: Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc 12: 170–196, 1972
32. Homan-Müller JWT, Weening RS, Roos D: Production of hydrogen peroxide by phagocytizing human granulocytes. J Lab Clin Med 85: 198–207, 1975
33. Curnutte JT, Babior BM: Biological defense mechanisms: the effect of bacteria and serum on superoxide production by granulocytes. J Clin Invest 53: 1662–1672, 1974
34. Goldstein IM, Cerquiera M, Lind S, et al: Evidence that the superoxide-generating system of human leukocytes is associated with the cell surface. J Clin Invest 59: 249–254, 1977
35. Briggs RT, Karnovsky ML, Karnovsky MJ: Hydrogen peroxide production in chronic granulomatous disease: a cytochemical study of reduced pyridine nucleotide oxidases. J Clin Invest 59: 1088–1098, 1977
36. Nicholls P, Schonbaum GR: Catalases, The Enzymes. Second edition. Edited by PD Boyer, H Lardy, K Myrbäck. New York, Academic Press, 1963, pp 198–200
37. Reed PW: Glutatione and the hexose monophosphate shunt in phagocytizing and hydrogen peroxide-treated rat leukocytes. J Biol Chem 244: 2459–2464, 1969
38. Baehner RL, Murrmann SK, Davis J, et al: The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest 56: 571–576, 1975
39. Baehner RL, Karnovsky ML: Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease. Science 162: 1277–1279, 1968
40. Baehner RL, Nathan DG: Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 278: 971–976, 1968
41. Segal AW, Peters TJ: Characterization of the enzyme defect in chronic granulomatous disease. Lancet 1: 1363–1365, 1976
42. Iyer GYN, Quastel JH: NADPH and NADH oxidation by guinea pig polymorphonuclear leucocytes. Can J Biochem 41: 427–434, 1963
43. Patriarca P, Cramer R, Moncalvo S, et al: Enzymatic basis of metabolic stimulation in leucocytes during phagocytosis: the role of activated NADPH oxidase. Arch Biochem Biophys 145: 255–262, 1971
44. Hohn DC, Lehrer RI: NADPH oxidase deficiency in X-linked chronic granulomatous disease. J Clin Invest 55: 707–713, 1975
45. Babior BM, Curnutte JT, McMurrich BJ: The particulate superoxide-forming system from human neutrophils: properties of the system and further evidence supporting its participation in the respiratory burst. J Clin Invest 58: 989–996, 1976
46. Takanaka K, O'Brien PJ: Mechanisms of H2O2 formation by leukocytes: properties of the NAD(P)H oxidase activity of intact leukocytes. Arch Biochem Biophys 169: 436–442, 1975
47. McPhail LC, DeChatelet LR, Shirley PS: Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes. J Clin Invest 58: 774–780, 1976
48. Curnutte JT, Karnovsky ML, Babior BM: Manganese-dependent NADPH oxidation by granulocyte particles: the role of superoxide and the nonphysiological nature of the manganese requirement. J Clin Invest 57: 1059–1067, 1976
49. Patriarca P, Dri P, Kakinuma K, et al: Studies on the mechanism of metabolic stimulation in polymorphonuclear leukocytes during phagocytosis. I. Evidence for superoxide anion involvement in the oxidation of NADPH2. Biochim Biophys Acta 385: 380–386, 1975
50. Babior BM, Kipnes RS: Superoxide-forming enzyme from human neutrophils: evidence for a flavin requirement. Blood 50: 517–524, 1977
51. Curnutte JT, Kipnes RS, Babior BM: Defect in pyridine nucleotide dependent superoxide production by a particulate fraction from the granulocytes of patients with chronic granulomatous disease. N Engl J Med 293: 628–632, 1975
52. Selvaraj RJ, Sbarra AJ: The role of the phagocyte in host-parasite interactions. VII. Di- and triphosphopyridine nucleotide kinetics during phagocytosis. Biochim Biophys Acta 141: 243–249, 1967
53. Cooper MR, DeChatelet LR, McCall CE, et al: Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest 51: 769–778, 1972
54. Holmes B, Page AR, Good RA: Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest 46: 1422–1432, 1967
55. Iverson D, DeChatelet LR, Spitznagel JK, et al: Comparison of NADH and NADPH oxidase activities in granules isolated from human polymorphonuclear leukocytes with a fluorimetric assay. J Clin Invest 59: 282–290, 1977
56. Segal AW: Nitroblue-tetrazolium tests. Lancet 2: 1248–1252, 1974
57. Nathan DG, Baehner RL, Weaver DK: Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest 48: 1895–1904, 1969
58. Segal AW, Trustey SF, Levi AJ: Re-evaluation of nitroblue tetrazolium tests. Lancet 2: 879–883, 1973
59. Baehner RL, Boxer LA, Davis J: The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood 48: 309–313, 1976
60. Allen RC, Stjernholm RL, Steele RH: Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun 47: 679–684, 1972
61. Webb LS, Keele BB Jr, Johnston RB Jr: Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase. Infect Immun 9: 1051–1056, 1974
62. Cheson BD, Christensen RL, Sperling R, et al: The origin of the chemiluminescence of phagocytosing granulocytes. J Clin Invest 58: 789–796, 1976
63. Stjernholm RL, Allen RC, Steele RH, et al: Impaired chemiluminescence during phagocytosis of opsonized bacteria. Infect Immun 7: 313–314, 1973
64. Babior BM, Curnutte JT, Kipnes RS: Biological defense mechanisms: evidence for the participation of superoxide in bacterial killing by xanthine oxidase. J Lab Clin Med 85: 235–244, 1975
65. Mandell GL: Catalase, superoxide dismutase, and virulence of Staphylococcus aureus: in vitro and in vivo studies with emphasis on staphylococcal-leukocyte interaction. J Clin Invest 55: 561–566, 1975
66. Gregory EM, Fridovich I: Oxygen metabolism in Lactobacillus plantarum. J Bacteriol 117: 166–169, 1974
67. Gregory EM, Yost FJ Jr, Fridovich I: Superoxide dismutases of Escherichia coli: intracellular localization and functions. J Bacteriol 115: 987–991, 1973
68. Drath DB, Karnovsky ML: Bactericidal activity of metal-mediated peroxide-ascorbate systems. Infect Immun 10: 1077–1083, 1974
69. Ehrenberg A, Agner K: The molecular weight of myeloperoxidase. Acta Chem Scand 12: 95, 1958
70. Bainton DF, Farquhar MG: Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. II. Cytochemistry and electron microscopy of bone marrow cells. J Cell Biol 39: 299–317, 1968
71. Lehrer RI, Cline MJ: Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48: 1478–1488, 1969
72. Salmon SE, Cline MJ, Schultz J, et al: Myeloperoxidase deficiency: immunological study of a genetic leukocyte defect. N Engl J Med 282: 250–253, 1970
73. Klebanoff SJ: Iodination of bacteria: a bactericidal mechanism. J Exp Med 126: 1063–1078, 1967
74. Klebanoff: Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 95: 2131–2138, 1968
75. Harrison JE, Schultz J: Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 251: 1371–1374, 1976
76. Klebanoff SJ: A peroxidase-mediated antimicrobial system in leukocytes. J Clin Invest 46: 1078, 1967
77. McRipley RJ, Sbarra AJ: Role of the phagocyte in host-parasite interactions. XII. Hydrogen peroxide-myeloperoxidase bactericidal system in the phagocyte. J Bacteriol 94: 1425–1430, 1967
78. Simmons SR, Karnovsky ML: Iodinating ability of various leukocytes and their bactericidal activity. J Exp Med 138: 44–63, 1973
79. Pincus SH, Klebanoff SJ: Quantitative leukocyte iodination. N Engl J Med 284: 744–750, 1971
80. Zgliczynski JM, Stelmaszynska T: Chlorinating ability of human phagocytosing leukocytes. Eur J Biochem 56: 157–162, 1975
81. McCall CE, DeChatelet LR, Cooper MR, et al: The effects of ascorbic acid on bactericidal mechanisms of neutrophils. J Infect Dis 124: 194–198, 1971
82. Zgliczynski JM, Stelmaszynska T, Ostrowski W, et al: Myeloperoxidase of human leukaemic leukocytes: oxidation of amino acids in the presence of hydrogen peroxide. Eur J Biochem 4: 540–547, 1968
83. Strauss RR, Paul BB, Jacobs AA, et al: Role of the phagocyte in host-parasite interactions. XXII. H2O2-dependent decarboxylation and deamination by myeloperoxidase and its relationship to antimicrobial activity. J Reticuloendothel Soc 7: 754–761, 1970
84. Strauss: Role of the phagocyte in host-parasite interactions. XXVII. Myeloperoxidase-H2O2-Cl−-mediated aldehyde formation and its relationship to antimicrobial activity. Infect Immun 3: 595–602, 1971
85. Paul BB, Jacobs AA, Strauss RR, et al: Role of the phagocyte in host-parasite interactions. XXIV. Aldehyde generation by the myeloperoxidase dase-H2O2-chloride antimicrobial system: a possible in vivo mechanism of action. Infect Immun 2: 414–418, 1970
86. Dorfman LM, Adams GE: Reactivity of the Hydroxyl Radical in Aqueous Solutions. Washington, DC, Government Printing Office, 1973, pp 4–6
87. Beauchamp C, Fridovich I: A mechanism for the production of ethylene from methional: the generation of hydroxyl radical by xanthine oxidase. J Biol Chem 245: 4641–4646, 1970
88. Weiss SJ, King GW, LoBuglio AF: Evidence for hydroxyl radical generation by human monocytes. J Clin Invest 60: 370–373, 1977
89. Tauber AI, Babior BM: Evidence for hydroxyl radical production by human neutrophils. J Clin Invest 60: 374–379, 1977
90. Weiss SJ, Rustagi PK, LoBuglio AF: Human granulocyte generation of hydroxyl radical. J Exp Med (in press)
91. Stossel TP, Mason RJ, Smith AL: Lipid peroxidation by human blood phagocytes. J Clin Invest 54: 638–645, 1974
92. Shohet SB, Pitt J, Baehner RL, et al: Lipid peroxidation in the killing of phagocytized pneumococci. Infect Immun 10: 1321–1328, 1974
93. Kearns DR: Physical and chemical properties of singlet molecular oxygen. Chem Rev 71: 395–427, 1971
94. Seliger HH: A photoelectric method for the measurement of spectra of light sources of rapidly varying intensities. Anal Biochem 1: 60–65, 1960
95. Kellogg EW III, Fridovich I: Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J Biol Chem 250: 8812–8817, 1975
96. Khan AU: Singlet molecular oxygen from superoxide anion and sensitized fluorescence of organic molecules. Science 168: 476–477, 1970
97. Krinsky NI: Biological roles of singlet oxygen, Singlet Oxygen. Edited by HH Wasserman, RW Murray. New York, Academic Press (in press)
98. Melander LC: Isotope Effects on Reaction Rates. New York, Ronald Press, 1960
99. Krinsky NI: Singlet excited oxygen as a mediator of the antibacterial action of leukocytes. Science 186: 363–365, 1974
100. Rosen H, Klebanoff SJ: Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system. J Biol Chem 252: 4803–4810, 1977